Literature DB >> 22784480

Overexpression of human antiquitin in E. coli: enzymatic characterization of twelve ALDH7A1 missense mutations associated with pyridoxine-dependent epilepsy.

Marion B Coulter-Mackie1, Ailin Li, Qun Lian, Eduard Struys, Sylvia Stockler, Paula J Waters.   

Abstract

Pyridoxine dependent epilepsy is an autosomal recessive disorder characterized by early onset seizures responsive to pyridoxine and caused by a defect in the α-aminoadipic semialdehyde dehydrogenase (antiquitin) gene (ALDH7A1). In order to characterize the effects of a series of twelve disease-associated ALDH7A1 missense mutations on antiquitin activity, we generated the mutations in a recombinant human antiquitin cDNA and expressed them in Escherichia coli. We developed an automated spectrophotometric assay of antiquitin enzymatic activity using the natural substrate α-aminoadipic semialdehyde. The substrate was generated using a recombinant lysine aminotransferase gene (lat) from Streptomyces clavuligerus. In the E. coli expression system all the mutants were stably expressed but lacked enzymatic activity. This is consistent with pathogenicity of these mutations in vivo.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22784480     DOI: 10.1016/j.ymgme.2012.06.008

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  8 in total

1.  Impact of disease-Linked mutations targeting the oligomerization interfaces of aldehyde dehydrogenase 7A1.

Authors:  David A Korasick; John J Tanner; Michael T Henzl
Journal:  Chem Biol Interact       Date:  2017-01-10       Impact factor: 5.192

2.  Glial localization of antiquitin: implications for pyridoxine-dependent epilepsy.

Authors:  Laura A Jansen; Robert F Hevner; William H Roden; Si Houn Hahn; Sunhee Jung; Sidney M Gospe
Journal:  Ann Neurol       Date:  2014-01-02       Impact factor: 10.422

3.  Structural and biochemical consequences of pyridoxine-dependent epilepsy mutations that target the aldehyde binding site of aldehyde dehydrogenase ALDH7A1.

Authors:  Adrian R Laciak; David A Korasick; Jesse W Wyatt; Kent S Gates; John J Tanner
Journal:  FEBS J       Date:  2019-07-25       Impact factor: 5.542

Review 4.  The genotypic spectrum of ALDH7A1 mutations resulting in pyridoxine dependent epilepsy: A common epileptic encephalopathy.

Authors:  Curtis R Coughlin; Michael A Swanson; Elaine Spector; Naomi J L Meeks; Kathryn E Kronquist; Mezhgan Aslamy; Michael F Wempe; Clara D M van Karnebeek; Sidney M Gospe; Verena G Aziz; Becky P Tsai; Hanlin Gao; Peter L Nagy; Keith Hyland; Silvy J M van Dooren; Gajja S Salomons; Johan L K Van Hove
Journal:  J Inherit Metab Dis       Date:  2019-02-22       Impact factor: 4.982

5.  Structural analysis of pathogenic mutations targeting Glu427 of ALDH7A1, the hot spot residue of pyridoxine-dependent epilepsy.

Authors:  Adrian R Laciak; David A Korasick; Kent S Gates; John J Tanner
Journal:  J Inherit Metab Dis       Date:  2019-12-01       Impact factor: 4.982

Review 6.  Impact of missense mutations in the ALDH7A1 gene on enzyme structure and catalytic function.

Authors:  David A Korasick; John J Tanner
Journal:  Biochimie       Date:  2020-09-19       Impact factor: 4.079

7.  Pyridoxine-Dependent Epilepsy in Zebrafish Caused by Aldh7a1 Deficiency.

Authors:  Izabella A Pena; Yann Roussel; Kate Daniel; Kevin Mongeon; Devon Johnstone; Hellen Weinschutz Mendes; Marjolein Bosma; Vishal Saxena; Nathalie Lepage; Pranesh Chakraborty; David A Dyment; Clara D M van Karnebeek; Nanda Verhoeven-Duif; Tuan Vu Bui; Kym M Boycott; Marc Ekker; Alex MacKenzie
Journal:  Genetics       Date:  2017-10-23       Impact factor: 4.562

Review 8.  Treatment, Therapy and Management of Metabolic Epilepsy: A Systematic Review.

Authors:  Vanessa Lin Lin Lee; Brandon Kar Meng Choo; Yin-Sir Chung; Uday P Kundap; Yatinesh Kumari; Mohd Farooq Shaikh
Journal:  Int J Mol Sci       Date:  2018-03-15       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.